???????Alumis cuts IPO size, but nets $250M for immune drug work [Yahoo! Finance]
Bristol-Myers Squibb Company (BMY)
Last bristol-myers squibb company earnings: 2/6 07:05 am
Check Earnings Report
US:NYSE Investor Relations:
bms.com/investors.html
Company Research
Source: Yahoo! Finance
Still, the IPO announced Thursday comes in below projections Alumis set earlier this week . The company had expected to sell about 17.7 million shares at $16 to $18 apiece, guaranteeing it at least $282.5 million. Instead, Alumis sold about 13.1 million shares at the low end of that range, and boosted its haul with a $40 million private stock sale to AyurMaya Capital Management, one of its top equity holders. Shares will begin trading Friday on the Nasdaq stock exchange. Even though the offering is smaller than Alumis intended, it's still the third-largest for a biotech this year, according to BioPharma Dive data . It also ranks among the most lucrative offerings since the final months of 2021, when the demand for sector IPOs cooled following a multi-year bull run. The company is capitalizing on interest in developers of drugs for autoimmune diseases, which have seen an uptick in venture funding, acquisitions and new stock offerings. Since the start of 2023, IPOs from Acelyrin
Show less
Read more
Impact Snapshot
Event Time:
BMY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BMY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BMY alerts
High impacting Bristol-Myers Squibb Company news events
Weekly update
A roundup of the hottest topics
BMY
News
- Is Bristol Myers Squibb Stock a Buy? [Yahoo! Finance]Yahoo! Finance
- Capturing the genAI boom for drug development [Yahoo! Finance]Yahoo! Finance
- Bristol-Myers Squibb (NYSE: BMY) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.MarketBeat
- Will Bristol Myers Squibb Stock Rebound To Its 2022 Highs Of $80? [Forbes]Forbes
- Bristol Myers Squibb (BMY) Stock Declines While Market Improves: Some Information for Investors [Yahoo! Finance]Yahoo! Finance
BMY
Earnings
- 4/25/24 - Miss
BMY
Sec Filings
- 6/25/24 - Form 11-K
- 6/25/24 - Form 11-K
- 6/25/24 - Form 11-K
- BMY's page on the SEC website